MALAT1 and hepatocellular carcinoma: Analysis of TCGA data from 369 hepatocellular carcinoma (HCC) patients and 50 healthy controls using the GEPIA2 database revealed that the expression level of MALAT1 in tumor tissues was significantly higher than that in normal tissues (Figure 1A).